u.s.

Hyundai Motor Group Increases U.S. Investment to $26 Billion to Accelerate Growth and Innovation

Hyundai Motor Group to invest USD 26 billion in the U.S. from 2025 to 2028The investment is expected to expand…

20 hours ago
UAB Qbit Financial Service Lawsuit Officially Dismissed by U.S. Court — Case Closed Without Findings of WrongdoingUAB Qbit Financial Service Lawsuit Officially Dismissed by U.S. Court — Case Closed Without Findings of Wrongdoing

UAB Qbit Financial Service Lawsuit Officially Dismissed by U.S. Court — Case Closed Without Findings of Wrongdoing

NEW YORK, Aug. 25, 2025 /PRNewswire/ -- UAB Qbit Financial Service, a Lithuanian financial services provider, has recently issued an…

1 day ago
Binti Launches First-of-its-Kind “AI for Social Services” Offering with Anthropic, Unleashing AI to Its Customer Base of Agencies Serving 46% of Child Welfare Across the U.S.Binti Launches First-of-its-Kind “AI for Social Services” Offering with Anthropic, Unleashing AI to Its Customer Base of Agencies Serving 46% of Child Welfare Across the U.S.

Binti Launches First-of-its-Kind “AI for Social Services” Offering with Anthropic, Unleashing AI to Its Customer Base of Agencies Serving 46% of Child Welfare Across the U.S.

Collaboration falls under Anthropic's "AI for Good" focus. Through embedding Claude, Binti will help social workers save administrative time and…

5 days ago
Keros Announces U.S. FDA Orphan Drug Designation Granted to KER-065 for the Treatment of Duchenne Muscular DystrophyKeros Announces U.S. FDA Orphan Drug Designation Granted to KER-065 for the Treatment of Duchenne Muscular Dystrophy

Keros Announces U.S. FDA Orphan Drug Designation Granted to KER-065 for the Treatment of Duchenne Muscular Dystrophy

August 20, 2025 09:48 ET  | Source: Keros Therapeutics, Inc. LEXINGTON, Mass., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Keros Therapeutics,…

6 days ago
U.S. Oral Surgery Management Moves into 31st StateU.S. Oral Surgery Management Moves into 31st State

U.S. Oral Surgery Management Moves into 31st State

IRVING, Texas, Aug. 14, 2025 (GLOBE NEWSWIRE) -- U.S. Oral Surgery Management (USOSM) – a management services organization that exclusively…

2 weeks ago
GameChange Solar Rises to Third Globally and Second in U.S. Solar Tracker MarketGameChange Solar Rises to Third Globally and Second in U.S. Solar Tracker Market

GameChange Solar Rises to Third Globally and Second in U.S. Solar Tracker Market

NORWALK, Conn., Aug. 12, 2025 /PRNewswire/ -- GameChange Solar has solidified its position as one of the world's leading solar…

2 weeks ago
DERMALOG JENETRIC Introduces Mobile Palm Scanner LIVETOUCH PALM to the U.S. MarketDERMALOG JENETRIC Introduces Mobile Palm Scanner LIVETOUCH PALM to the U.S. Market

DERMALOG JENETRIC Introduces Mobile Palm Scanner LIVETOUCH PALM to the U.S. Market

At the 2025 IAI Conference in Orlando, DERMALOG JENETRIC will debut the ultra-compact LIVETOUCH PALM. Combining mobility, durability and intuitive…

3 weeks ago
Zenara Pharma Receives U.S. FDA Approval for First Generic of Sertraline Hydrochloride Capsules with 180-Day CGT ExclusivityZenara Pharma Receives U.S. FDA Approval for First Generic of Sertraline Hydrochloride Capsules with 180-Day CGT Exclusivity

Zenara Pharma Receives U.S. FDA Approval for First Generic of Sertraline Hydrochloride Capsules with 180-Day CGT Exclusivity

HYDERABAD, India, August 1, 2025 /PRNewswire/ -- Zenara Pharma Private Limited ("Zenara"), a Biophore company, today announced that it has received final…

4 weeks ago
Egg Medical Announces U.S. Patent and Trademark Office Issues Final Rejection of All Claims in Rampart IC’s Radiation Shield Patent Following a Reexamination ChallengeEgg Medical Announces U.S. Patent and Trademark Office Issues Final Rejection of All Claims in Rampart IC’s Radiation Shield Patent Following a Reexamination Challenge

Egg Medical Announces U.S. Patent and Trademark Office Issues Final Rejection of All Claims in Rampart IC’s Radiation Shield Patent Following a Reexamination Challenge

ST. PAUL, Minn., July 30, 2025 /PRNewswire/ -- In a significant development in an ongoing legal dispute, the U.S. Patent and…

4 weeks ago
NewGen Announces Strategic Acquisition of Cytometry Technology and Assets to Support Planned U.S. ExpansionNewGen Announces Strategic Acquisition of Cytometry Technology and Assets to Support Planned U.S. Expansion

NewGen Announces Strategic Acquisition of Cytometry Technology and Assets to Support Planned U.S. Expansion

July 29, 2025 09:00 ET  | Source: NewGenIvf Limited The new cytometry technology enhances accessibility, safety, and efficiency in sperm-sorting…

4 weeks ago